APP and Alzheimer disease: FoA blocked Aβ oligomer-induced neuronal toxicity and increased cell viability by stimulating methylation potential and DNMT activity, decreasing presenilin 1 (PS1) and APP expression, thus altering promoter methylation in AD transgenic mice [205].